Hayward, Calif.-based Biolog has garnered another grant from the National Institutes of Health for a new application — this time in the area of antimicrobial drug development — for its Phenotype Microarray cellular array technology.

The additional $450,000 of funding will augment the approximately $2 million in separate grants that Biolog has received in the past three months to support the development of the Phenotype Microarray for applications ranging from detecting bioterrorism agents to functional genomic studies on yeast, Saccharomyces cerevisae.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.